10-Q: Procter & Gamble Reports Mixed Results in Q3 2024, Impacted by Intangible Asset Impairment

Procter & Gamble's Q3 2024 results show a slight increase in net sales but are impacted by a significant non-cash impairment charge related to the Gillette brand.

Summary

• Procter & Gamble's net sales for the third quarter of 2024 increased by 1% to $20.2 billion compared to the same period last year.
• The company's organic sales, which exclude the impact of acquisitions, divestitures, and foreign exchange, grew by 3%.
• Net earnings for the quarter rose by 10% to $3.8 billion, while diluted earnings per share (EPS) increased by 11% to $1.52.
• However, the nine-month results were impacted by a $1.3 billion non-cash impairment charge on the Gillette intangible asset, resulting in a 4% increase in net earnings to $11.8 billion.
• Core EPS, excluding the impairment and restructuring charges, increased by 15% to $5.19 for the nine-month period.
• The company's operating cash flow for the nine months was $14.1 billion, and adjusted free cash flow was $12.0 billion, with an adjusted free cash flow productivity of 93%.

Sentiment

Score: 5

Explanation: The document presents a mixed picture with positive sales growth and margin improvements offset by a significant impairment charge and negative foreign exchange impacts. The underlying business shows strength, but the impairment raises concerns about asset valuation and future performance.

Positives

• The company achieved a 3% increase in organic sales for the quarter, demonstrating solid underlying business performance.
• Gross margin improved significantly by 300 basis points in Q3 2024, driven by productivity savings and lower commodity costs.
• Net earnings and diluted EPS both saw double-digit growth in Q3 2024.
• Core EPS for the nine-month period increased by 15%, indicating strong underlying profitability when excluding non-recurring items.
• The company generated strong operating cash flow of $14.1 billion for the nine-month period.

Negatives

• The company experienced a $1.3 billion non-cash impairment charge on the Gillette intangible asset, impacting overall net earnings.
• Unfavorable foreign exchange had a negative impact on net sales and earnings.
• SG&A expenses increased as a percentage of net sales due to higher marketing and overhead spending.
• The Beauty segment experienced a decline in net earnings due to unfavorable product mix and higher effective tax rate.
• The Baby Care segment saw a decrease in net sales due to lower unit volume.

Risks

• The company is exposed to global macroeconomic factors, geopolitical tensions, and foreign exchange fluctuations, which can impact net sales and earnings.
• Fluctuations in commodity and input material prices, transportation costs, and other inflationary pressures can affect the company's costs.
• The company faces risks related to disruptions in manufacturing, supply, and distribution operations.
• Changes in government policies, including tax and trade regulations, could impact the company's financial results.
• The war between Russia and Ukraine continues to pose operational and financial risks.
• The Gillette indefinite-lived intangible asset is susceptible to further impairment risk due to adverse changes in the business or macroeconomic environment.

Future Outlook

The company expects to record incremental restructuring charges of $1.0 to $1.5 billion after tax, primarily in certain Enterprise Markets, in the fiscal years ending June 30, 2024 and 2025. The company also expects to reduce outstanding shares through direct share repurchases at a value of $5 to $6 billion in fiscal year 2024.

Management Comments

• Management uses non-GAAP measures to evaluate performance and make operating decisions.
• Management believes that these non-GAAP measures provide useful perspective on underlying business trends and results.
• Management also uses certain market share and market consumption estimates to evaluate performance relative to competition.

Industry Context

P&G operates in the highly competitive fast-moving consumer goods industry, facing competition from global, regional, and local players, as well as private-label brands. The company's performance is influenced by macroeconomic factors, consumer trends, and competitive dynamics in various markets and product segments.

Comparison to Industry Standards

• P&G's gross margin improvement of 300 basis points in Q3 2024 is a positive sign, indicating effective cost management and pricing strategies, which is a key metric for consumer goods companies.
• The 3% organic sales growth is a moderate result compared to some high-growth consumer goods companies, but it reflects P&G's large scale and mature markets.
• The 15% increase in core EPS for the nine-month period is a strong performance, demonstrating the company's ability to generate profits when excluding non-recurring items.
• The adjusted free cash flow productivity of 93% is a solid result, indicating efficient cash generation relative to earnings.
• The impairment charge on the Gillette intangible asset is a significant event, highlighting the challenges in maintaining brand value in a competitive market, similar to other large consumer goods companies that have faced similar issues with legacy brands.

Stakeholder Impact

• Shareholders will be impacted by the impairment charge and the resulting decrease in net earnings, but also by the increase in core EPS and the share repurchase program.
• Employees may be affected by the restructuring program and ongoing organizational changes.
• Customers may see changes in product offerings and pricing due to the company's strategic initiatives.
• Suppliers may be impacted by the company's supplier finance program and changes in payment terms.

Next Steps

• The company will continue to implement its restructuring program in certain Enterprise Markets.
• The company will focus on managing costs and improving productivity.
• The company will continue to monitor and manage risks related to macroeconomic conditions, foreign exchange, and geopolitical tensions.
• The company will continue to execute its share repurchase program.

Key Dates

Keywords

Procter & Gamble, P&G, Consumer Goods, Financial Results, Quarterly Report, Net Sales, Earnings Per Share, Organic Sales, Gillette, Impairment, Restructuring, Cash Flow, Gross Margin, Foreign Exchange